🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to assess the pharmacokinetics (PK) ...
Status
Completed
Location
Xuhui Central Hospital
Start Date
2020-10-26
Trial ID
NCT04555733
Treatments Being Tested
This study will be a single center, open-label, drug-drug interaction study...
Status
Completed
Location
PPD Development LLC
Start Date
2014-02
Trial ID
NCT02085967
Treatments Being Tested
E2006-A001-108 is a 4-period crossover study designed to demonstrate that t...
Status
Completed
Location
NeuroTrials Research, Inc
Start Date
2016-11-21
Trial ID
NCT03008447
Part A: The purpose of this study is to evaluate the safety and tolerabilit...
Status
Completed
Location
Clinilabs, Inc.
Start Date
2011-10-05
Trial ID
NCT01463098
This study will be conducted to evaluate the effects on cognitive performan...
Status
Completed
Location
Syneos Health
Start Date
2018-03-12
Trial ID
NCT03483636
Treatments Being Tested
This is a single-center, open-label, randomized crossover study being condu...
Status
Completed
Location
PPD Development, LLC
Start Date
2012-08
Trial ID
NCT01673880
Treatments Being Tested
This is an open-label, single-dose, randomized crossover study of single or...
Status
Completed
Location
PPD Development LLC
Start Date
2014-02
Trial ID
NCT02089412
Treatments Being Tested
This study will be conducted to evaluate the effect of lemborexant 10 milli...
Status
Completed
Location
Worldwide Clinical Trials
Start Date
2018-02-05
Trial ID
NCT03451110
Treatments Being Tested
This is a multicenter, multiple dose, randomized, double-blind, placebo-con...
Status
Completed
Location
Multiple Locations
Start Date
2013-11-13
Trial ID
NCT01995838
This study will be conducted to demonstrate, using polysomnography, that le...
Status
Completed
Location
Jasper Summit Research LLC
Start Date
2016-05-31
Trial ID
NCT02783729
Treatments Being Tested